First, ccRCC cells were treated with human recombinant CCL24 protein, and CCK-8 proliferation assays were performed to show that recombinant CCL24 enhanced the proliferation of ccRCC cells in a dose-dependent manner (Fig. 4a, b). Here, CCL24 is linked to nonpapillary renal cell carcinoma.